Z
Zoetis Inc. (ZTS)
NYQ – Real vaqt narxi. Valyuta: USD
76.94
+0.27 (0.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
77.15
+0.21 (0.27%)
Bozordan keyin: May 12, 2026, 8:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
76.94
+0.27 (0.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
77.15
+0.21 (0.27%)
Bozordan keyin: May 12, 2026, 8:00 PM EDT
Zoetis Inc. AQSh va xalqaro miqyosda hayvonlar salomatligi sanoati uchun dori-darmonlar, vaktsinalar, diagnostika mahsulotlari va xizmatlari, bioqurilmalar, genetik testlar va aniq chorva sog'lig'i echimlarini kashf qilish, ishlab chiqish, ishlab chiqarish va tijoratlashtirish bilan shug'ullanadi. Kompaniya asosan itlar, mushuklar va otlarni o'z ichiga olgan uy hayvonlari; shuningdek, qoramol, cho'chqa, parranda, baliq va qo'ylarni o'z ichiga olgan chorva mollari uchun mahsulotlarni tijoratlashtiradi. Shuningdek, u parazitlarga qarshi vositalar, vaktsinalar, dermatologiya, infeksiyalarga qarshi vositalar, og'riq va sedatsiya, boshqa farmatsevtika va hayvonlar salomatligi diagnostikasini taklif etadi. Bundan tashqqari, kompaniya hayvonlar salomatligi diagnostikasini taqdim etadi, jumladan, joyida diagnostika mahsulotlari, asboblar va reagentlar, tezkor immunoassay testlari, referent laboratoriya to'plamlari va xizmatlari, hamda qon glyukozasi monitorlari; va boshqa farmatsevtika bo'lmagan mahsulotlar, jumladan, ozuqaviy moddalar, shuningdek, bioqurilmalar, genetik testlar va aniq chorva sog'lig'i sohasidagi mahsulotlar va xizmatlar. U o'z mahsulotlarini veterinarlar, chorva mollari yetishtiruvchilar va uy hayvonlari egalariga sotadi. Kompaniya hayvonlar salomatligi uchun yangi antibiotiklarni kashf qilish va ishlab chiqish bo'yicha Blacksmith Medicines, Inc. bilan hamkorlik qilgan. Zoetis Inc. 2012 yilda tashkil etilgan va shtab-kvartirasi Nyu-Jersi shtatining Parsippany shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Robert J. Polzer Ph.D. | Scientific Advisor |
| Mr. Jamie Brannan | Executive VP & Chief Commercial Officer |
| Mr. Keith Sarbaugh | Executive VP & Chief Digital and Technology Officer |
| Mr. Nick Ashton | Executive VP and President of Global Manufacturing & Supply |
| Mr. Steven Frank | Vice President of Investor Relations |
| Mr. Wetteny N. Joseph CPA | Executive VP & CFO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | zts-20260507.htm |
| 2026-04-08 | DEFA14A | a2026zoetisna.htm |
| 2026-02-12 | 8-K | zts-20260212.htm |
| 2026-02-05 | 8-K | zts-20260205.htm |
| 2025-12-18 | 8-K | d35588d8k.htm |
| 2025-12-11 | 8-K | zts-20251211.htm |
| 2025-12-02 | 8-K | zts-20251202.htm |
| 2025-11-04 | 8-K | zts-20251104.htm |
| 2025-10-28 | 8-K | zts-20251023.htm |
| 2025-10-09 | 8-K | zts-20251009.htm |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Chief Sustainability Officer |
| Ms. Julie A. Fuller | Executive VP, Chief Human Resources Officer & Global Operations |
| Ms. Kristin C. Peck | CEO & Director |
| Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary |